Pipeline of Peripheral Neuropathy Market H1 2016 Covering 15 Companies

RnRMarketResearch adds Peripheral Neuropathy Market research to its database.

Pune, India – March 29, 2016 /MarketersMedia/ —

Companies Involved in Therapeutics Development are Araim Pharmaceuticals, Inc., Arcturus Therapeutics, Inc, aTyr Pharma, Inc., Baxalta Incorporated, CSL Limited, GeNeuro SA, INSYS Therapeutics, Inc., Mitsubishi Tanabe Pharma Corporation, Neuren Pharmaceuticals Limited, Neurocentrx Pharma Ltd., Pfizer Inc., Polyneuron Pharmaceuticals AG, RegeneRx Biopharmaceuticals, Inc., Sanofi and Teijin Pharma Limited.

The report provides comprehensive information on the therapeutics under development for Peripheral Neuropathy (Sensory Neuropathy), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Peripheral Neuropathy (Sensory Neuropathy) and features dormant and discontinued projects.

Inquire more about this research at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=516253 .

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

• The report provides a snapshot of the global therapeutic landscape of Peripheral Neuropathy (Sensory Neuropathy)
• The report reviews pipeline therapeutics for Peripheral Neuropathy (Sensory Neuropathy) by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved Peripheral Neuropathy (Sensory Neuropathy) therapeutics and enlists all their major and minor projects
• The report assesses Peripheral Neuropathy (Sensory Neuropathy) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news related to pipeline therapeutics for Peripheral Neuropathy (Sensory Neuropathy)

Complete research report of 100 pages with TOC is available at http://www.rnrmarketresearch.com/peripheral-neuropathy-sensory-neuropathy-pipeline-review-h1-2016-market-report.html .

For more information about us, please visit http://www.rnrmarketresearch.com/

Contact Info:
Name: Ritesh Tiwari
Organization: RnR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, Maharashtra 411013, India
Phone: +1888 391 54 41

Source: http://marketersmedia.com/pipeline-of-peripheral-neuropathy-market-h1-2016-covering-15-companies/108575

Release ID: 108575